- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 319/04 - 1,3-DioxanesHydrogenated 1,3-dioxanes
Patent holdings for IPC class C07D 319/04
Total number of patents in this class: 35
10-year publication summary
|
0
|
2
|
3
|
1
|
0
|
1
|
0
|
2
|
1
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| International Business Machines Corporation | 61747 |
2 |
| Merck Patent GmbH | 5752 |
2 |
| Sumitomo Chemical Company, Limited | 9109 |
2 |
| The General Hospital Corporation | 4801 |
2 |
| Takeda Pharmaceutical Company Limited | 2721 |
2 |
| Rhodia Operations | 1553 |
2 |
| BASF SE | 21098 |
1 |
| The Regents of the University of California | 20303 |
1 |
| Centre National de La Recherche Scientifique | 10706 |
1 |
| Dow Global Technologies Inc. | 775 |
1 |
| The Regents of the University of Michigan | 4793 |
1 |
| Northwestern University | 3457 |
1 |
| A.P. Pharma, Inc. | 3 |
1 |
| Bio-Pharm Solutions Co., Ltd. | 60 |
1 |
| BioLab Ltd. | 5 |
1 |
| Central Glass Company, Limited | 1273 |
1 |
| Emcure Pharmaceuticals Limited | 69 |
1 |
| Fukushima Medical University | 41 |
1 |
| IBM United Kingdom Limited | 4203 |
1 |
| JNC Corporation | 1507 |
1 |
| Other owners | 9 |